Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients

NCT: NCT05271019 · COMPLETED

NCT IDNCT05271019
StatusCOMPLETED
Start Date2022-02-04
Completion2025-01-15
SponsorPuerta de Hierro University Hospital (OTHER)
First posted
Last updated

Brief Summary

Lung transplantation is an effective therapeutic option in the end-stage of chronic respiratory diseases. Lung transplantation improves lung function in terms of capacity and volume. However, the transplanted patient still suffers from muscle weakness and exercise intolerance. In recent years, respiratory physiotherapy work has intensified in critically ill patients with respiratory muscle weakness and the application of inspiratory muscle training (IMT), which has been shown in several studies to increase inspiratory muscle strength (IMT), improve ventilation and reduce the sensation of shortness of breath. Despite this emerging evidence, inspiratory muscle training (IMT) is not standard practice in most ICUs around the world, nor is it included in a protocolised manner among the components of a pulmonary rehabilitation programme. Given the limited evidence, the investigators propose to conduct this randomised controlled clinical trial in lung transplant recipients. The study will compare two groups of transplanted patients, a control group that will follow the rehabilitation programme and standard medical care and another experimental group that will also perform inspiratory muscle training. This study aims to analyse the effect of IMT on inspiratory muscle strength, exercise capacity and quality of life in lung transplant patients.

Frequently Asked Questions

What is Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients?

Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients is a clinical trial registered under NCT05271019. Current status: COMPLETED.

What is the status of NCT05271019?

The current status of NCT05271019 (Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients) is: COMPLETED.

When did Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients start?

Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients started on 2022-02-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.